Classification of Pharmaceutical Reference Standards under GST Entry No. 80: Implications of 12% Integrated Tax The Pharmaceutical Reference Standards (PRS) imported and supplied by the applicant were classified under Tariff Item 3822 00 90 of the Customs Tariff ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Classification of Pharmaceutical Reference Standards under GST Entry No. 80: Implications of 12% Integrated Tax
The Pharmaceutical Reference Standards (PRS) imported and supplied by the applicant were classified under Tariff Item 3822 00 90 of the Customs Tariff Act. The ruling determined that they are covered under Entry No. 80 of Schedule-II to Notification No. 1/2017-Integrated Tax (Rate), attracting a levy of Integrated Tax at the rate of 12%. This decision was based on the interpretation that PRS, as prepared laboratory reagents, fall under the category of "All diagnostic kits and reagents" and should be subject to a 12% GST rate.
Issues Involved: 1. Classification of Pharmaceutical Reference Standards (PRS) under the Customs Tariff Act. 2. Applicability of GST rate under Notification No. 01/2017-IT (R) for PRS.
Issue-wise Detailed Analysis:
1. Classification of Pharmaceutical Reference Standards (PRS) under the Customs Tariff Act:
The applicant, engaged in the distribution of Pharmaceutical Reference Standards (PRS), sought clarity on the classification of PRS under the Customs Tariff Act. PRS are described as prepared laboratory reagents intended exclusively for analytical, calibrating, and referencing purposes, not for detection, diagnosis, or use as drugs. The classification under Tariff Item 3822 00 90 was supported by the decision in LGC Promochem India Pvt. Ltd. v. Commissioner of Customs & Service Tax, Bangalore, which was upheld by the Supreme Court. The ruling classified PRS as prepared laboratory reagents under Chapter Heading 3822 of the Customs Tariff Act.
2. Applicability of GST rate under Notification No. 01/2017-IT (R) for PRS:
The applicant sought an advance ruling to determine whether PRS should attract a GST rate of 12% under Entry No. 80 of Schedule II (covering "All diagnostic kits and reagents") or 18% under Entry No. 453 of Schedule III (a residuary entry for unspecified goods). The applicant argued that PRS, as prepared laboratory reagents, should fall under Entry No. 80 of Schedule II, attracting a 12% GST rate. They emphasized that the term "reagent" in Entry No. 80 is broad enough to include both diagnostic and laboratory reagents, supported by the HSN Explanatory Notes and previous rulings.
Findings and Discussion:
The authority considered the submissions and noted the similarity with the case of M/s. Chromachemie Laboratory Pvt. Ltd., where it was ruled that Entry No. 80 of Schedule II applies to all diagnostic kits and reagents, including laboratory reagents. The Karnataka Appellate Authority for Advance Ruling clarified that the phrase "All diagnostic kits and reagents" encompasses the entire range of diagnostic and laboratory reagents under Heading 3822, and the legislative intent was to apply a 12% GST rate to all such reagents. The principle of ejusdem generis was deemed inapplicable as the general term "All" precedes the specific enumeration.
Ruling:
The Pharmaceutical Reference Standards (Prepared Laboratory Reagents) imported and supplied by the applicant, classified under Tariff Item 3822 00 90 of the Customs Tariff Act, 1975, are covered under Entry No. 80 of Schedule-II to Notification No. 1/2017-Integrated Tax (Rate), attracting a levy of Integrated Tax at the rate of 12%.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.